Keywords

Cardiopulmonary Resuscitation; Diabetes Mellitus, Type 2; Heart Failure; Intensive Care; Neurology

Selected publications

1. Wurm, R. et al., 2016. Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles. Heart, 102(19), pp.1544-1551. Available at: http://dx.doi.org/10.1136/heartjnl-2015-308711.
2. Wurm, R.*, Adlbrecht, C.* et al., 2014. Peri-interventional endothelin-A receptor blockade improves long-term outcome in patients with ST-elevation acute myocardial infarction. Thrombosis and Haemostasis, 112(1), pp.176-182. Available at: http://dx.doi.org/10.1160/TH13-10-0832.
3. Wurm, R., et al., 2017, Non-occlusive mesenteric ischaemia in out of hospital cardiac arrest survivors. European heart journal Acute cardiovascular care.
4. Pavo, N. et al., 2016. Renin-Angiotensin System Fingerprints of Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology, 68(25), pp.2912-2914. Available at: http://dx.doi.org/10.1016/j.jacc.2016.10.017.
5. Resl, M. et al., 2016. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes. Heart, 102(24), pp.1963-1968. Available at: http://dx.doi.org/10.1136/heartjnl-2015-308949.